Michael George Zaki Ghali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michael George Zaki Ghali has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
George Zaki Ghali
United States Environmental Protection Agency, Arlington, USA
13 shared publicationsEmil Zaki Ghali
Department of Medicine, Inova Alexandria Hospital, Alexandria, VA, USA; Department of Cardiothoracic Surgery, El Gomhoureya General Hospital, Alexandria, Egypt
8 shared publicationsVisish M. Srinivasan
Department of Neurological Surgery, Baylor College of Medicine, Houston, Texas, USA
7 shared publicationsPeter Kan
Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA
6 shared publications- Gavin Wayne Britz
Department of Neurosurgery, Houston Methodist Hospital, Houston, Texas, USA
3 shared publications - Peter Kan
Neurosurgery, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA
3 shared publications
Latest Publications
- RetractionOpen Access
- 8 March 2022
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (11) , 11215
Retraction Note to: β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor‑β arrestin scaffold‑mediated activation of extracellular‑regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra‑neuraxial carcinoma
- 8 March 2022
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (11) , 11215
RetractionOpen AccessRetraction Note to: β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor‑β arrestin scaffold‑mediated activation of extracellular‑regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra‑neuraxial carcinoma
- RetractionOpen Access
- 30 June 2021
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 20 (2) , 527
Retraction: Ghali MGZ, et al. Mechanisms underlying the generation of autonomorespiratory coupling amongst the respiratory central pattern generator, sympathetic oscillators, and cardiovagal premotoneurons. Journal of Integrative Neuroscience. 2020; 19: 521–560
The above-mentioned article [1], published online on 30 September 2020, has been withdrawn. The retraction has been issued following additional information based on an issue raised by the KAROLINSKA INSTITUTET, Sweden, in regards to a disputed domain name. This was received by IMR Press and reviewed by the Chief Editor.
- 30 June 2021
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 20 (2) , 527
RetractionOpen AccessRetraction: Ghali MGZ, et al. Mechanisms underlying the generation of autonomorespiratory coupling amongst the respiratory central pattern generator, sympathetic oscillators, and cardiovagal premotoneurons. Journal of Integrative Neuroscience. 2020; 19: 521–560
The above-mentioned article [1], published online on 30 September 2020, has been withdrawn. The retraction has been issued following additional information based on an issue raised by the KAROLINSKA INSTITUTET, Sweden, in regards to a disputed domain name. This was received by IMR Press and reviewed by the Chief Editor.
- Open Access
- 1 October 2020
- Published by Elsevier in Neurobiology of Disease
- Vol. 144, 105022
Structure and function of the perivascular fluid compartment and vertebral venous plexus: Illumining a novel theory on mechanisms underlying the pathogenesis of Alzheimer's, cerebral small vessel, and neurodegenerative diseases
- 1 October 2020
- Published by Elsevier in Neurobiology of Disease
- Vol. 144, 105022
Open AccessStructure and function of the perivascular fluid compartment and vertebral venous plexus: Illumining a novel theory on mechanisms underlying the pathogenesis of Alzheimer's, cerebral small vessel, and neurodegenerative diseases
- RetractedOpen Access
- 30 September 2020
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 19 (3) , 521-560
Mechanisms underlying the generation of autonomorespiratory coupling amongst the respiratory central pattern generator, sympathetic oscillators, and cardiovagal premotoneurons
The respiratory rhythm and pattern and sympathetic and parasympathetic outflows are generated by distinct, though overlapping, propriobulbar arrays of neuronal microcircuit oscillators constituting networks utilizing mutual excitatory and inhibitory neuronal interactions, residing principally within the metencephalon and myelencephalon, and modulated by synaptic influences from the cerebrum, thalamus, hypothalamus, cerebellum, and mesencephalon and ascending influences deriving from peripheral stimuli relayed by cranial nerve afferent axons. Though the respiratory and cardiovascular regulatory effector mechanisms utilize distinct generators, there exists significant overlap and interconnectivity amongst and between these oscillators and pathways, evidenced reciprocally by breathing modulation of sympathetic oscillations and sympathetic modulation of neural breathing. These coupling mechanisms are well-demonstrated coordinately in sympathetic- and respiratory-related central neuronal and efferent neurogram recordings and quantified by the findings of cross-correlation, spectra, and coherence analyses, combined with empirical interventions including lesioning and pharmacological agonist and antagonist microinjection studies, baroloading, barounloading, and hypoxic and/or hypercapnic peripheral and/or central chemoreceptor stimulation. Sympathetic and parasympathetic central neuronal and efferent neural discharge recordings evidence classic fast rhythms produced by propriobulbar neuronal networks located within the medullary division of the lateral tegmental field, coherent with cardiac sympathetic nerve discharge. These neural efferent nerve discharges coordinately evidence slow synchronous oscillations, constituted by Traube Hering (i.e., high frequency), Mayer wave (i.e., medium or low frequency), and vasogenic autorhythmicity (i.e., very low frequency) wave spectral bands. These oscillations contribute to coupling neural breathing, sympathetic oscillations, and parasympathetic cardiovagal premotoneuronal activity. The mechanisms underlying the origins of and coupling amongst, these waves remains to be unresolved.
- 30 September 2020
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 19 (3) , 521-560
RetractedOpen AccessMechanisms underlying the generation of autonomorespiratory coupling amongst the respiratory central pattern generator, sympathetic oscillators, and cardiovagal premotoneurons
The respiratory rhythm and pattern and sympathetic and parasympathetic outflows are generated by distinct, though overlapping, propriobulbar arrays of neuronal microcircuit oscillators constituting networks utilizing mutual excitatory and inhibitory neuronal interactions, residing principally within the metencephalon and myelencephalon, and modulated by synaptic influences from the cerebrum, thalamus, hypothalamus, cerebellum, and mesencephalon and ascending influences deriving from peripheral stimuli relayed by cranial nerve afferent axons. Though the respiratory and cardiovascular regulatory effector mechanisms utilize distinct generators, there exists significant overlap and interconnectivity amongst and between these oscillators and pathways, evidenced reciprocally by breathing modulation of sympathetic oscillations and sympathetic modulation of neural breathing. These coupling mechanisms are well-demonstrated coordinately in sympathetic- and respiratory-related central neuronal and efferent neurogram recordings and quantified by the findings of cross-correlation, spectra, and coherence analyses, combined with empirical interventions including lesioning and pharmacological agonist and antagonist microinjection studies, baroloading, barounloading, and hypoxic and/or hypercapnic peripheral and/or central chemoreceptor stimulation. Sympathetic and parasympathetic central neuronal and efferent neural discharge recordings evidence classic fast rhythms produced by propriobulbar neuronal networks located within the medullary division of the lateral tegmental field, coherent with cardiac sympathetic nerve discharge. These neural efferent nerve discharges coordinately evidence slow synchronous oscillations, constituted by Traube Hering (i.e., high frequency), Mayer wave (i.e., medium or low frequency), and vasogenic autorhythmicity (i.e., very low frequency) wave spectral bands. These oscillations contribute to coupling neural breathing, sympathetic oscillations, and parasympathetic cardiovagal premotoneuronal activity. The mechanisms underlying the origins of and coupling amongst, these waves remains to be unresolved.
- Open Access
- 14 August 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (33) , e20746
Trimethoprim-sulfamethoxazole-induced hyponatremia in an elderly lady with Achromobacter xylosoxidans pneumonia
Rationale: Hyponatremia occurs frequently in the hospital setting and may be attributable to a host of etiologies. Drugs are frequently implicated. Trimethoprim-sulfamethoxazole (TMP/SMX) represents a well-recognized pharmacologic precipitant of drug-induced hyponatremia, with several reports extant in the retrievable literature. Nephrologists thus debate the mechanisms giving rise to TMP/SMX-induced hyponatremia and the precise mechanism by which treatment with TMP/SMX generates reductions of serum sodium concentration remain controversial. The agent has a well-known effect of antagonizing the effects of aldosterone upon the distal nephron. Renal salt wasting and the syndrome of inappropriate antidiuretic hormone secretion represent implicated mechanistic intermediaries in TMP/SMX-induced hyponatremia. Patient concerns: The patient endorsed no explicit concerns. Diagnoses: We describe the case of an 83-year-old female clinically diagnosed with pneumonia found to have an initial serum sodium in the range of 130 to 134 mEq/L consistent with mild hyponatremia upon admission. Sputum cultures grew Achromobacter xylosoxidans susceptible to TMP/SMX. The patient's serum sodium concentration precipitously decline following institution of treatment with TMP/SMX to 112 to 114 mEq/L during the course of 5 days. Interventions: Severe hyponatremia proved recalcitrant to initial therapy with supplemental salt tabs and standard doses of the vasopressin receptor antagonist tolvaptan. Outcomes: Escalating doses of tolvaptan increased the patient's sodium to 120 to 124 mEq/L. The patient was transferred to another hospital for further management. During her stay, the patient did not exhibit frank or obvious clinical features consistent with hyponatremia nor readily appreciable evidence of volume depletion. Lessons: TMP/SMX represents a frequent, though underreported cause of hyponatremia in the hospital setting several authors believe natriuresis may represent the most common mechanism underlying TMP/SMX-induced hyponatremia. Evidence implicating natriuresis to be mechanistic in TMP/SMX-induced hyponatremia include clinically appreciable hypovolemia and resolution of hyponatremia with oral or intravenous salt repletion. Salt repletion failed to monotherapeutically enhance our patient's hyponatremiadisfavoring renal salt wasting as originately mechanistic. Contemporaneous refractoriness of serum sodium to fluid restriction nor standard doses of tolvaptan confounded our initial attempts to mechanistically attribute the patient's hyponatremia to a specific cause. Clinical euvolemia and rapid response of hyponatremia to exceptionally high doses of tolvaptan strongly favors syndrome of inappropriate antidiuretic hormone to represent the chief mechanism by which TMP/SMX exacerbates hyponatremia.
- 14 August 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (33) , e20746
Open AccessTrimethoprim-sulfamethoxazole-induced hyponatremia in an elderly lady with Achromobacter xylosoxidans pneumonia
Rationale: Hyponatremia occurs frequently in the hospital setting and may be attributable to a host of etiologies. Drugs are frequently implicated. Trimethoprim-sulfamethoxazole (TMP/SMX) represents a well-recognized pharmacologic precipitant of drug-induced hyponatremia, with several reports extant in the retrievable literature. Nephrologists thus debate the mechanisms giving rise to TMP/SMX-induced hyponatremia and the precise mechanism by which treatment with TMP/SMX generates reductions of serum sodium concentration remain controversial. The agent has a well-known effect of antagonizing the effects of aldosterone upon the distal nephron. Renal salt wasting and the syndrome of inappropriate antidiuretic hormone secretion represent implicated mechanistic intermediaries in TMP/SMX-induced hyponatremia. Patient concerns: The patient endorsed no explicit concerns. Diagnoses: We describe the case of an 83-year-old female clinically diagnosed with pneumonia found to have an initial serum sodium in the range of 130 to 134 mEq/L consistent with mild hyponatremia upon admission. Sputum cultures grew Achromobacter xylosoxidans susceptible to TMP/SMX. The patient's serum sodium concentration precipitously decline following institution of treatment with TMP/SMX to 112 to 114 mEq/L during the course of 5 days. Interventions: Severe hyponatremia proved recalcitrant to initial therapy with supplemental salt tabs and standard doses of the vasopressin receptor antagonist tolvaptan. Outcomes: Escalating doses of tolvaptan increased the patient's sodium to 120 to 124 mEq/L. The patient was transferred to another hospital for further management. During her stay, the patient did not exhibit frank or obvious clinical features consistent with hyponatremia nor readily appreciable evidence of volume depletion. Lessons: TMP/SMX represents a frequent, though underreported cause of hyponatremia in the hospital setting several authors believe natriuresis may represent the most common mechanism underlying TMP/SMX-induced hyponatremia. Evidence implicating natriuresis to be mechanistic in TMP/SMX-induced hyponatremia include clinically appreciable hypovolemia and resolution of hyponatremia with oral or intravenous salt repletion. Salt repletion failed to monotherapeutically enhance our patient's hyponatremiadisfavoring renal salt wasting as originately mechanistic. Contemporaneous refractoriness of serum sodium to fluid restriction nor standard doses of tolvaptan confounded our initial attempts to mechanistically attribute the patient's hyponatremia to a specific cause. Clinical euvolemia and rapid response of hyponatremia to exceptionally high doses of tolvaptan strongly favors syndrome of inappropriate antidiuretic hormone to represent the chief mechanism by which TMP/SMX exacerbates hyponatremia.
- Retracted
- 31 July 2020
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 76 (6) , I-XI
RETRACTED ARTICLE: Two dimensional speckle tracking echocardiography detects cardiac allograft stage III vasculopathy in recipients of heart transplants with preserved systolic function
Facile identification of cardiac allograft vasculopathy (CAV), extensively prevalently identifiable across recipients of cardiac explanted allografts, has proven challenging using non-invasive modalities exclusively. We consequently sought to evaluate diagnostic precision and accuracy of two-dimensional speckle tracking echocardiography (2D-STE) to the end of detecting international society heart & lung transplantation stage III graft vasculopathy (ISHLT-CAV3) in individuals having received cardiac allografts by the meritorious pre-mortem scripted or verbalised indication of a benevolent benefactor personally or impersonally to a consanguineous Beloved to permit a sequential series of cuts to be made upon faux one’s true corporal remnant successive to the terminal micro-epoch concluding viable organ perfusion possessing dynamic contractility of the myocardium failing to recede approximately a standard deviation from the central tendency metrically corresponding with the fraction of residual blood remaining within the chambered confines of the left ventricular muscle (LVEF). We successively sought to evaluate 39 individuals having unfortunately succumbed to the undesired incipient inaugural development of ISHLTCAV3 and two receding the quantal equivalent of the triplicate of fortnight beneficiaries of explanted cardiac allografts failing to manifest findings correlatively indicating abnormal patterns of haemo-expressive contraction or haemo-receptive relaxation of the myocardial wall identifiable by inspection, auscultation, palpation, and percussion of the integumental or mucosal surfaces of the patient or non-invasive static and dynamic visualisation of organ function. We conducted transthoracic echocardiography (TTE) within 90 days successively succeeding evaluation of the co-explanted co-transplanted arteries treadingly and penetratively perfusing the myocardium by transarterial digital subtraction angiography and intravascular ultrasound. We successively evaluated metrics inclusive of left ventricular longitudinal (LVLS), radial, and circumferential strain (i.e. LVLS, LVRS, and LVCS, respectively) and strain rates (i.e. LVLSR, LVCSR, and LVRSR, respectively) and ‘synchrony’ off-line. We subsequently designated longitudinal time to peak strain (>58.2 msec) failing to recede two standard deviations supernumerary to the meanof the cohort to the end of identifying an echocardiographically significant quantal pseudo-continuous reductions of left ventricular synchrony. Mean age among cardiac allograft transplant recipients without or with evidence of coronary arteriopathy approximated 65 years (72% male) and 55 years (75% male), respectively. Left ventricular ejection fraction failed to distinguish among cardiac allograft transplant patients failing to, or para-successfully successfully, developed stage III coronary allograft arteriopathy (ISHLTCAV3). Cardiac allograft recipients having categorically developed diagnostically defined ISHLTCAV3 exhibited greater duration of QRS complex, elevation of the arterial blood pressure magnitude to pre-pathologically augmentably subtend from a baseline commensurate with the population central tendency, dysglycemia conforming to the definition of type II diabetes mellitus, and low density lipoprotein, compared with a complementary set of counterparts fortuitously para-serendipitously failing to develop a degree of coronary arterial vasculopathy commensurate with criteria requisitely typifying ISHLTCAV3, though exhibited a non-significant trend towards relative categorical decrements in the mass of the left ventricle. Coronary arterial vasculature successively subjected to co-explantation co-transplantation with myocardia from benevolent individuals having exceeded their God-given years of life to distinguished non-needy needy recipients of cardiac allografts developing ISHLTCAV3 exhibited significantly greater left ventricular longitudinal strain, compared with complement conduited conduits haemo-functionally curvilinearly extending from the coronary ostia intimate with, though separate from, the sinuses of Valsalva, failing to develop ISHLTCAV3, though left ventricular circumferential strain and left ventricular radial strain and left ventricular longitudinal, circumferential, and radial strain rates failed to constitute distinguishing metrics. Categorical reductions of left ventricular synchrony extending time to peak longitudinal strain to exceed two-tenths of one percentum exceeding 58 s failed to occur among approximately two percentum of patients developing interval ISHLTCAV3, contrasted with 98 percentum of individuals fortuitously failing to develop stage III coronary allograft arteriopathy. Among cardiac allograft transplant recipients developing interval ISHLTCAV3, integrating left ventricular longitudinal strain with respect to time across the population range generated a mean value of 0.72. Enhanced left ventricular and time-to-peak (>58.2 msec) longitudinal strain constituted sensitive and specific markers identifying recipients of cardiac allografts developing ISHLTCAV3 retaining ejection fraction of the left ventricle failing to recede from lower limits of normal, the prevalently and nearly exclusively utilised metric of myocardial systolic function. These two echocardiographic metrics may be effectively employed to the end of predicting and diagnosing severe vasculopathy.
- 31 July 2020
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 76 (6) , I-XI
RetractedRETRACTED ARTICLE: Two dimensional speckle tracking echocardiography detects cardiac allograft stage III vasculopathy in recipients of heart transplants with preserved systolic function
Facile identification of cardiac allograft vasculopathy (CAV), extensively prevalently identifiable across recipients of cardiac explanted allografts, has proven challenging using non-invasive modalities exclusively. We consequently sought to evaluate diagnostic precision and accuracy of two-dimensional speckle tracking echocardiography (2D-STE) to the end of detecting international society heart & lung transplantation stage III graft vasculopathy (ISHLT-CAV3) in individuals having received cardiac allografts by the meritorious pre-mortem scripted or verbalised indication of a benevolent benefactor personally or impersonally to a consanguineous Beloved to permit a sequential series of cuts to be made upon faux one’s true corporal remnant successive to the terminal micro-epoch concluding viable organ perfusion possessing dynamic contractility of the myocardium failing to recede approximately a standard deviation from the central tendency metrically corresponding with the fraction of residual blood remaining within the chambered confines of the left ventricular muscle (LVEF). We successively sought to evaluate 39 individuals having unfortunately succumbed to the undesired incipient inaugural development of ISHLTCAV3 and two receding the quantal equivalent of the triplicate of fortnight beneficiaries of explanted cardiac allografts failing to manifest findings correlatively indicating abnormal patterns of haemo-expressive contraction or haemo-receptive relaxation of the myocardial wall identifiable by inspection, auscultation, palpation, and percussion of the integumental or mucosal surfaces of the patient or non-invasive static and dynamic visualisation of organ function. We conducted transthoracic echocardiography (TTE) within 90 days successively succeeding evaluation of the co-explanted co-transplanted arteries treadingly and penetratively perfusing the myocardium by transarterial digital subtraction angiography and intravascular ultrasound. We successively evaluated metrics inclusive of left ventricular longitudinal (LVLS), radial, and circumferential strain (i.e. LVLS, LVRS, and LVCS, respectively) and strain rates (i.e. LVLSR, LVCSR, and LVRSR, respectively) and ‘synchrony’ off-line. We subsequently designated longitudinal time to peak strain (>58.2 msec) failing to recede two standard deviations supernumerary to the meanof the cohort to the end of identifying an echocardiographically significant quantal pseudo-continuous reductions of left ventricular synchrony. Mean age among cardiac allograft transplant recipients without or with evidence of coronary arteriopathy approximated 65 years (72% male) and 55 years (75% male), respectively. Left ventricular ejection fraction failed to distinguish among cardiac allograft transplant patients failing to, or para-successfully successfully, developed stage III coronary allograft arteriopathy (ISHLTCAV3). Cardiac allograft recipients having categorically developed diagnostically defined ISHLTCAV3 exhibited greater duration of QRS complex, elevation of the arterial blood pressure magnitude to pre-pathologically augmentably subtend from a baseline commensurate with the population central tendency, dysglycemia conforming to the definition of type II diabetes mellitus, and low density lipoprotein, compared with a complementary set of counterparts fortuitously para-serendipitously failing to develop a degree of coronary arterial vasculopathy commensurate with criteria requisitely typifying ISHLTCAV3, though exhibited a non-significant trend towards relative categorical decrements in the mass of the left ventricle. Coronary arterial vasculature successively subjected to co-explantation co-transplantation with myocardia from benevolent individuals having exceeded their God-given years of life to distinguished non-needy needy recipients of cardiac allografts developing ISHLTCAV3 exhibited significantly greater left ventricular longitudinal strain, compared with complement conduited conduits haemo-functionally curvilinearly extending from the coronary ostia intimate with, though separate from, the sinuses of Valsalva, failing to develop ISHLTCAV3, though left ventricular circumferential strain and left ventricular radial strain and left ventricular longitudinal, circumferential, and radial strain rates failed to constitute distinguishing metrics. Categorical reductions of left ventricular synchrony extending time to peak longitudinal strain to exceed two-tenths of one percentum exceeding 58 s failed to occur among approximately two percentum of patients developing interval ISHLTCAV3, contrasted with 98 percentum of individuals fortuitously failing to develop stage III coronary allograft arteriopathy. Among cardiac allograft transplant recipients developing interval ISHLTCAV3, integrating left ventricular longitudinal strain with respect to time across the population range generated a mean value of 0.72. Enhanced left ventricular and time-to-peak (>58.2 msec) longitudinal strain constituted sensitive and specific markers identifying recipients of cardiac allografts developing ISHLTCAV3 retaining ejection fraction of the left ventricle failing to recede from lower limits of normal, the prevalently and nearly exclusively utilised metric of myocardial systolic function. These two echocardiographic metrics may be effectively employed to the end of predicting and diagnosing severe vasculopathy.
- RetractedOpen Access
- 16 July 2020
- Published by Wiley in Experimental Physiology
- Vol. 105 (8) , 1232-1255
Retracted: Control of hypoglossal pre‐inspiratory discharge
New Findings What is the topic of this review? This review explores the modulatory role of lung vagal afferents and intra‐neuraxial and carotid body chemoreceptors upon hypoglossal pre‐inspiratory activity. What advances does it highlight? Pre‐inspiratory activity manifesting in hypoglossal neural efferent discharge may be potentiated by mechanical interruption of vagal continuity and challenge with administration of a hypoxic and/or hypercapnic gas mixture and attenuated by static and/or dynamic pulmonary stretch. Differential excitability of, or premotoneuronal volleys exhibiting distinct spatiotemporal patterns of discharge arriving at, motoneurons residing within the hypoglossal motor nucleus may emergently generate phase‐spanning pre‐inspiratory inspiratory activity of hypoglossal neural efferent discharge manifest at the population level. Abstract The hypoglossal nerve (XII) innervates muscles mediating excursive movements of the tongue. The population discharge of hypoglossalmotoneuronal axons constituting the hypoglossal nerve precedes and extends through the inspiratory epoch. The epoch subtended between the onsets of hypoglossal and phrenic neural discharge constitutes so‐called pre‐inspiration. Hypoglossal pre‐inspiratory neural discharge serendipitously displaces the tongue along a tensor reducing upper airway resistance anticipative of succeeding inspiratory efforts. Hypoglossal motoneurons exhibiting discharge onset during pre‐inspiration experience successive hyperpolarization of membrane voltage and attenuation of unitary spiking frequency, although a subset may, paradoxically and state‐dependently, exhibit depolarization of membrane voltage and augmentation of neuronal spiking frequency, by dynamic stretch placed upon the alveolar walls and interstitium. Marked static elevation of positive‐end expiratory pressure may induce hypoglossal bursting decoupled from phasic rhythmic phrenic discharge. Augmentation of the amplitude and/or duration of hypoglossal inspiratory discharge during successive pre‐inspiratory and inspiratory epochs by inhalation of a hypoxic and/or hypercapnic gas mixture remains restrained in the presence of intact vagal inputs and is potentiated by interruptions of vagal continuity. Unravelling the mechanisms underlying the genesis of pre‐inspiratory activity will inform our understanding of respiratory rhythm generation and pattern shaping. In the present work, I seek to explore the mechanisms underlying modulation of hypoglossal pre‐inspiratory discharge by hypercapnia, hypoxia and static and dynamic lung stretch placed upon hypoglossal pre‐inspiratory activity, the mechanisms underlying the generation of hypoglossal pre‐inspiratory activity, and the extent of microanatomical and functional overlap between propriobulbar interneuronal microcircuits generating hypoglossal pre‐inspiratory activity and propriobulbar interneuronal microcircuit oscillators generating pre‐inspiratory activity inaugurally inducing respiratory rhythmic activity and thus use experimental data from previous work and that developed by other investigators to explore the modulatory role of lung vagal afferents and intra‐neuraxial and carotid body chemoreceptors upon hypoglossal pre‐inspiratory activity.
- 16 July 2020
- Published by Wiley in Experimental Physiology
- Vol. 105 (8) , 1232-1255
RetractedOpen AccessRetracted: Control of hypoglossal pre‐inspiratory discharge
New Findings What is the topic of this review? This review explores the modulatory role of lung vagal afferents and intra‐neuraxial and carotid body chemoreceptors upon hypoglossal pre‐inspiratory activity. What advances does it highlight? Pre‐inspiratory activity manifesting in hypoglossal neural efferent discharge may be potentiated by mechanical interruption of vagal continuity and challenge with administration of a hypoxic and/or hypercapnic gas mixture and attenuated by static and/or dynamic pulmonary stretch. Differential excitability of, or premotoneuronal volleys exhibiting distinct spatiotemporal patterns of discharge arriving at, motoneurons residing within the hypoglossal motor nucleus may emergently generate phase‐spanning pre‐inspiratory inspiratory activity of hypoglossal neural efferent discharge manifest at the population level. Abstract The hypoglossal nerve (XII) innervates muscles mediating excursive movements of the tongue. The population discharge of hypoglossalmotoneuronal axons constituting the hypoglossal nerve precedes and extends through the inspiratory epoch. The epoch subtended between the onsets of hypoglossal and phrenic neural discharge constitutes so‐called pre‐inspiration. Hypoglossal pre‐inspiratory neural discharge serendipitously displaces the tongue along a tensor reducing upper airway resistance anticipative of succeeding inspiratory efforts. Hypoglossal motoneurons exhibiting discharge onset during pre‐inspiration experience successive hyperpolarization of membrane voltage and attenuation of unitary spiking frequency, although a subset may, paradoxically and state‐dependently, exhibit depolarization of membrane voltage and augmentation of neuronal spiking frequency, by dynamic stretch placed upon the alveolar walls and interstitium. Marked static elevation of positive‐end expiratory pressure may induce hypoglossal bursting decoupled from phasic rhythmic phrenic discharge. Augmentation of the amplitude and/or duration of hypoglossal inspiratory discharge during successive pre‐inspiratory and inspiratory epochs by inhalation of a hypoxic and/or hypercapnic gas mixture remains restrained in the presence of intact vagal inputs and is potentiated by interruptions of vagal continuity. Unravelling the mechanisms underlying the genesis of pre‐inspiratory activity will inform our understanding of respiratory rhythm generation and pattern shaping. In the present work, I seek to explore the mechanisms underlying modulation of hypoglossal pre‐inspiratory discharge by hypercapnia, hypoxia and static and dynamic lung stretch placed upon hypoglossal pre‐inspiratory activity, the mechanisms underlying the generation of hypoglossal pre‐inspiratory activity, and the extent of microanatomical and functional overlap between propriobulbar interneuronal microcircuits generating hypoglossal pre‐inspiratory activity and propriobulbar interneuronal microcircuit oscillators generating pre‐inspiratory activity inaugurally inducing respiratory rhythmic activity and thus use experimental data from previous work and that developed by other investigators to explore the modulatory role of lung vagal afferents and intra‐neuraxial and carotid body chemoreceptors upon hypoglossal pre‐inspiratory activity.
- RetractedOpen Access
- 10 July 2020
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 14, 395
RETRACTED: Mechanisms Contributing to the Generation of Mayer Waves
Mayer waves may synchronize overlapping propriobulbar interneuronal microcircuits constituting the respiratory rhythm and pattern generator, sympathetic oscillators, and cardiac vagal preganglionic neurons. Initially described by Sir Sigmund Mayer in the year 1876 in the arterial pressure waveform of anesthetized rabbits, authors have since extensively observed these oscillations in recordings of hemodynamic variables, including arterial pressure waveform, peripheral resistance, and blood flow. Authors would later reveal the presence of these oscillations in sympathetic neural efferent discharge and brainstem and spinal zones corresponding with sympathetic oscillators. Mayer wave central tendency proves highly consistent within, though the specific frequency band varies extensively across, species. Striking resemblance of the Mayer wave central tendency to the species-specific baroreflex resonant frequency has led the majority of investigators to comfortably presume, and generate computational models premised upon, a baroreflex origin of these oscillations. Empirical interrogation of this conjecture has generated variable results and derivative interpretations. Sinoaortic denervation and effector sympathectomy variably reduces or abolishes spectral power contained within the Mayer wave frequency band. Refractorines of Mayer wave generation to barodeafferentation lends credence to the hypothesis these waves are chiefly generated by brainstem propriobulbar and spinal cord propriospinal interneuronal microcircuit oscillators and likely modulated by the baroreflex. The presence of these waves in unitary discharge of medullary lateral tegmental field and rostral ventrolateral medullary neurons (contemporaneously exhibiting fast sympathetic rhythms [2–6 and 10 Hz bands]) in spectral variability in vagotomized pentobarbital-anesthetized and unanesthetized midcollicular (i.e., intercollicular) decerebrate cats supports genesis of Mayer waves by supraspinal sympathetic microcircuit oscillators. Persistence of these waves following high cervical transection in vagotomized unanesthetized midcollicular decerebrate cats would seem to suggest spinal sympathetic microcircuit oscillators generate these waves. The widespread presence of Mayer waves in brainstem sympathetic-related and non-sympathetic-related cells would seem to betray a general tendency of neurons to oscillate at this frequency. We have thus presented an extensive and, hopefully cohesive, discourse evaluating, and evolving the interpretive consideration of, evidence seeking to illumine our understanding of origins of, and insight into mechanisms contributing to, the genesis of Mayer waves. We have predicated our arguments and conjectures in the substance and matter of empirical data, though we have occasionally waxed philosophical beyond these traditional confines in suggesting interpretations exceeding these limits. We believe our synthesis and interpretation of the relevant literature will fruitfully inspire future studies from the perspective of a more intimate appreciation and conceptualization of network mechanisms generating oscillatory variability in neuronal and neural outputs. Our evaluation of Mayer waves informs a novel set of disciplines we term quantum neurophysics extendable to describing subatomic reality. Beyond informing our appreciation of mechanisms generating sympathetic oscillations, Mayer waves may constitute an intrinsic property of neurons extant throughout the cerebrum, brainstem, and spinal cord or reflect an emergent property of interactions between arteriogenic and neuronal oscillations.
- 10 July 2020
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 14, 395
RetractedOpen AccessRETRACTED: Mechanisms Contributing to the Generation of Mayer Waves
Mayer waves may synchronize overlapping propriobulbar interneuronal microcircuits constituting the respiratory rhythm and pattern generator, sympathetic oscillators, and cardiac vagal preganglionic neurons. Initially described by Sir Sigmund Mayer in the year 1876 in the arterial pressure waveform of anesthetized rabbits, authors have since extensively observed these oscillations in recordings of hemodynamic variables, including arterial pressure waveform, peripheral resistance, and blood flow. Authors would later reveal the presence of these oscillations in sympathetic neural efferent discharge and brainstem and spinal zones corresponding with sympathetic oscillators. Mayer wave central tendency proves highly consistent within, though the specific frequency band varies extensively across, species. Striking resemblance of the Mayer wave central tendency to the species-specific baroreflex resonant frequency has led the majority of investigators to comfortably presume, and generate computational models premised upon, a baroreflex origin of these oscillations. Empirical interrogation of this conjecture has generated variable results and derivative interpretations. Sinoaortic denervation and effector sympathectomy variably reduces or abolishes spectral power contained within the Mayer wave frequency band. Refractorines of Mayer wave generation to barodeafferentation lends credence to the hypothesis these waves are chiefly generated by brainstem propriobulbar and spinal cord propriospinal interneuronal microcircuit oscillators and likely modulated by the baroreflex. The presence of these waves in unitary discharge of medullary lateral tegmental field and rostral ventrolateral medullary neurons (contemporaneously exhibiting fast sympathetic rhythms [2–6 and 10 Hz bands]) in spectral variability in vagotomized pentobarbital-anesthetized and unanesthetized midcollicular (i.e., intercollicular) decerebrate cats supports genesis of Mayer waves by supraspinal sympathetic microcircuit oscillators. Persistence of these waves following high cervical transection in vagotomized unanesthetized midcollicular decerebrate cats would seem to suggest spinal sympathetic microcircuit oscillators generate these waves. The widespread presence of Mayer waves in brainstem sympathetic-related and non-sympathetic-related cells would seem to betray a general tendency of neurons to oscillate at this frequency. We have thus presented an extensive and, hopefully cohesive, discourse evaluating, and evolving the interpretive consideration of, evidence seeking to illumine our understanding of origins of, and insight into mechanisms contributing to, the genesis of Mayer waves. We have predicated our arguments and conjectures in the substance and matter of empirical data, though we have occasionally waxed philosophical beyond these traditional confines in suggesting interpretations exceeding these limits. We believe our synthesis and interpretation of the relevant literature will fruitfully inspire future studies from the perspective of a more intimate appreciation and conceptualization of network mechanisms generating oscillatory variability in neuronal and neural outputs. Our evaluation of Mayer waves informs a novel set of disciplines we term quantum neurophysics extendable to describing subatomic reality. Beyond informing our appreciation of mechanisms generating sympathetic oscillations, Mayer waves may constitute an intrinsic property of neurons extant throughout the cerebrum, brainstem, and spinal cord or reflect an emergent property of interactions between arteriogenic and neuronal oscillations.
- 5 July 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 416, 117014
Galenic Pial Arteriovenous Fistulas in Adults
- 5 July 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 416, 117014
Galenic Pial Arteriovenous Fistulas in Adults
- RetractedOpen Access
- 19 June 2020
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 15 (12) , 2217-2234
Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Nafamostat mesylate, an apparent soi-disant panacea of sorts, is widely used to anticoagulate patients undergoing hemodialysis or cardiopulmonary bypass, mitigate the inflammatory response in patients diagnosed with acute pancreatitis, and reverse the coagulopathy of patients experiencing the commonly preterminal disseminated intravascular coagulation in the Far East. The serine protease inhibitor nafamostat mesylate exhibits significant neuroprotective effects in the setting of neurovascular ischemia. Nafamostat mesylate generates neuroprotective effects by attenuating the enzymatic activity of serine proteases, neuroinflammatory signaling cascades, and the endoplasmic reticulum stress responses, downregulating excitotoxic transient receptor membrane channel subfamily 7 cationic currents, modulating the activity of intracellular signal transduction pathways, and supporting neuronal survival (brain-derived neurotrophic factor/TrkB/ERK1/2/CREB, nuclear factor kappa B. The effects collectively reduce neuronal necrosis and apoptosis and prevent ischemia mediated disruption of blood-brain barrier microarchitecture. Investigational clinical applications of these compounds may mitigate ischemic reperfusion injury in patients undergoing cardiac, hepatic, renal, or intestinal transplant, preventing allograft rejection, and treating solid organ malignancies. Neuroprotective effects mediated by nafamostat mesylate support the wise conduct of randomized prospective controlled trials in Western countries to evaluate the clinical utility of this compound.
- 19 June 2020
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 15 (12) , 2217-2234
RetractedOpen AccessNafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Nafamostat mesylate, an apparent soi-disant panacea of sorts, is widely used to anticoagulate patients undergoing hemodialysis or cardiopulmonary bypass, mitigate the inflammatory response in patients diagnosed with acute pancreatitis, and reverse the coagulopathy of patients experiencing the commonly preterminal disseminated intravascular coagulation in the Far East. The serine protease inhibitor nafamostat mesylate exhibits significant neuroprotective effects in the setting of neurovascular ischemia. Nafamostat mesylate generates neuroprotective effects by attenuating the enzymatic activity of serine proteases, neuroinflammatory signaling cascades, and the endoplasmic reticulum stress responses, downregulating excitotoxic transient receptor membrane channel subfamily 7 cationic currents, modulating the activity of intracellular signal transduction pathways, and supporting neuronal survival (brain-derived neurotrophic factor/TrkB/ERK1/2/CREB, nuclear factor kappa B. The effects collectively reduce neuronal necrosis and apoptosis and prevent ischemia mediated disruption of blood-brain barrier microarchitecture. Investigational clinical applications of these compounds may mitigate ischemic reperfusion injury in patients undergoing cardiac, hepatic, renal, or intestinal transplant, preventing allograft rejection, and treating solid organ malignancies. Neuroprotective effects mediated by nafamostat mesylate support the wise conduct of randomized prospective controlled trials in Western countries to evaluate the clinical utility of this compound.